ENTOFENTOFOTC
Loading
Cash Flow PerformanceStable
Percentile Rank57
3Y CAGR-4.1%
5Y CAGR-2.4%
Studio
Year-over-Year Change

Operating cash flow minus capital expenditures

3Y CAGR
-4.1%/yr
vs +2.3%/yr prior
5Y CAGR
-2.4%/yr
Consistent
Acceleration
-6.4pp
Decelerating
Percentile
P57
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
3 yr
Consecutive declineStable
PeriodValueYoY Change
2025$1.33B-1.9%
2024$1.35B-1.8%
2023$1.38B-8.4%
2022$1.50B+2.0%
2021$1.48B-1.7%
2020$1.50B+13.9%
2019$1.32B-4.1%
2018$1.37B+14.6%
2017$1.20B+10.8%
2016$1.08B-